Stenham Asset Management Ltd / ACRS
Stenham Asset Management Ltd’s Aclaris Therapeutics Inc Position
Does Stenham Asset Management Ltd own Aclaris Therapeutics Inc (ACRS)? Not currently — the last reported position was 283.5K shares worth $7M in Q1 2021; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$7M
Q1 2021
Shares
283.5K
% of Portfolio
+5.04%
Quarters Held
2
position exited
Position History ACRS
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Stenham Asset Management Ltd’s full portfolio or all institutional holders of ACRS.